The tip of the iceberg in ATTRv: when to start carrier monitoring and when to initiate treatment?

J Neurol Neurosurg Psychiatry. 2024 May 14;95(6):487. doi: 10.1136/jnnp-2023-332842.

Authors

Davide Pareyson¹, Silvia Fenu²

Affiliations

¹ Unit of Rare Neurological Diseases, Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy davide.pareyson@istituto-besta.it.
² Unit of Rare Neurological Diseases, Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.

PMID: 38071548
DOI: 10.1136/jnnp-2023-332842

No abstract available

Keywords: AMYLOID; NEUROPATHOLOGY; NEUROPATHY; NEUROPHYSIOLOGY.

Publication types

Editorial

MeSH terms

Amyloid Neuropathies, Familial* / diagnosis
Humans